TITLE

Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome

AUTHOR(S)
Rizzo, Maria; Leo, Stefania; Franciscis, Pasquale; Colacurci, Nicola; Paolisso, Giuseppe
PUB. DATE
February 2014
SOURCE
Age;Feb2014, Vol. 36 Issue 1, p265
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This study aims to compare the effects of low-dose emidrate estradiol/drospirenone (E2/DRSP) vs low-dose emidrate estradiol/dydrogesterone (E2/DG) combination on the mean amplitude of glycemic excursions (MAGE) value in postmenopausal women affected by metabolic syndrome (MS). One hundred sixty postmenopausal women were recruited to receive a treatment with oral doses of E2/1 mg plus drospirenone/2 mg (E2/DRSP group) or oral dose of E2/1 mg plus dydrogesterone/5 mg (E2/DG group) for 6 months. At enrollment and after 6 months, anthropometric, metabolic, and inflammatory parameters have been assessed. MAGE, evaluated during 48-h continuous subcutaneous glucose monitoring (CSGM), allowed us to assess daily glucose fluctuations at baseline and after 6 months. After hormone therapy, both groups showed a significant decline in fasting plasma glucose levels ( p < 0.05), while only E2/DRSP group showed a statistically significant decline in waist circumferences, post-prandial glycemia, LDL, plasma triglycerides, MAGE, HOMA index, and plasma IL-6 ( p < 0.05) levels. In the whole population ( n = 160), after 6 months of indicated therapy, changes in fasting plasma glucose and PAI-1 levels correlated with the changes in MAGE values, while only in E2/DRSP group that MAGE reduction was positively associated with a stronger decrease in waist circumferences, triglycerides, and TNF-α plasma levels. The independent effect of hormone therapy (HT) on reduction in MAGE value has been tested in three different multiple linear regression models. HT resulted to be associated with MAGE, independent of other confounding variables. Although both groups had a decline in fasting plasma glucose, only drospirenone treatment revealed positive effects on glycemic excursions and insulin sensitivity, induced favorable changes in lipid profile, and showed an improvement of inflammatory indices in postmenopausal women with MS.
ACCESSION #
93447555

 

Related Articles

  • Electrocardiographic Abnormalities Associated with the Metabolic Syndrome and Its Components: The Multi-Ethnic Study of Atherosclerosis. Ebong, Imo A.; Bertoni, Alain G.; Soliman, Elsayed Z.; Guo, Mengye; Sibley, Christopher T.; Chen, Yii-Der I.; Rotter, Jerome I.; Chen, Yi-Chun; Goff, David C. // Metabolic Syndrome & Related Disorders;Apr2012, Vol. 10 Issue 2, p92 

    Background: The association between metabolic syndrome and electrocardiographic (ECG) abnormalities is not well established. Methods: ECG tracings of 6,765 men and women aged 45-84 years, free of clinical cardiovascular disease, from the Multi-Ethnic Study of Atherosclerosis were obtained...

  • Asociación entre síndrome metabólico y gravedad del asma. Pantoja-Alcantar, Juan Manuel; Segura-Méndez, Nora Hilda; Vargas-Ortega, Guadalupe; González-Virla, Baldomero G. // Revista Alergia de Mexico;ene-mar2012, Vol. 59 Issue 1, p3 

    Background: The association between obesity and asthma is well known but there is few information that relates metabolic syndrome with asthma. Both diseases share pathophysiologic bases, including inflammation, which suggests that they could present associated events. Objective: To determine the...

  • Metabolic Syndrome: Potential Benefit From Specific Nutritional Dietary Therapy. El Shebini, Salwa M.; Hussein, Ahmed M.S.; Moaty, Maha I.A.; Mohamed, Magda S.; Ahmed, Nihad H.; Hanna, Laila M.; Tapozada, Salwa T. // Journal of Applied Sciences Research;Mar2013, Vol. 9 Issue 3, p1940 

    The aim was to investigate the effect of a dietary supplement on the different criteria of the metabolic syndrome (Mets). Fifty eight obese Mets women with mean age of 48.8±0.87 years and mean Body Mass Index (BMI) of 38.6± 0.90 kg/m², volunteered for 8 weeks, divided into two equal...

  • Correlation between Hormonal Statuses and Metabolic Syndrome in Postmenopausal Women. Ziaei, Saeideh; Mohseni, Hajar // Journal of Family & Reproductive Health;Jun2013, Vol. 7 Issue 2, p63 

    Objective: To compare the hormonal status in postmenopausal women with and without metabolic syndrome. Materials and methods: In this cross sectional study 110 postmenopausal women were enrolled. Participants completed a questionnaire and underwent a medical exam and serum evaluation for serum...

  • A little exercise after menopause reduces metabolic syndrome.  // Research Review (International Council on Active Aging);Jun2013, Vol. 13 Issue 23, p2 

    The article focuses on a study in the June 15, 2013 issue of "American Journal of Cardiology" which revealed that low-to-moderate intensity cardiorespiratory exercise has lowered components of the metabolic syndrome in postmenopausal women who exercised at different levels for six months.

  • Correlation between liver fat content with dyslipidemia and Insulin resistance. Saran, Sanjay; Philip, Rajeev; Gutch, Manish; Tyagi, Rajeev; Agroiya, Puspalata; Gupta, Keshav Kumar // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS355 

    Total 33 obese patients were studied to determine correlation in between liver fat content with dyslipidemia and insulin resistance. Liver and spleen attenuation measurements were taken with three regions of interests (ROIs) from the liver and two ROIs from the spleen. Hepatic attenuation...

  • Hypothalamic Apolipoprotein E Effects on Plasma Lipids in obese rats with metabolic syndrome. Bunea, M.; Scheau, C.; Moldovan, R.; Ciornei, C.; Papacocea, R.; Tache, S.; Badarau, A. // Proceedings of the Physiological Society;2013, p753P 

    The metabolic syndrome is defined by raised values of plasma cholesterol, raised plasma triglycerides and elevated waist circumference (1), among other parameters. Nevertheless, the role of apolipoprotein E (ApoE) in the on set of obesity in the metabolic syndrome remains unclear, although...

  • Determination of Charactestic Blood Organic Parameters in Periparatal and Peak Lactation Dairy Cows. Milorad, KRSMANOVIĆ; DJOKOVIĆ, Radojica; BOJKOVSKI, Jovan // Bulletin of the University of Agricultural Sciences & Veterinary;2013, Vol. 70 Issue 2, p258 

    The blood levels of glucose, total proteins, triglycerides, free fatty acids, total cholesterol, total proteins, albumnin, urea, total bilirubin were evaluated in peripartal and peak lactating dairy cows within physiological range. The measure values of the test parameters in puerperal dairy...

  • Alpha Lipoic Acid, Inositol Reduce Metabolic Syndrome in Postmenopausal Women... reprinted with permission from the August 28, 2013 issue of the Trials journal.  // Life Extension;Dec2013, p36 

    A reprint of the article "Alpha Lipoic Acid, Inositol Reduce Metabolic Syndrome in Postmenopausal Women" which appeared in the August 28, 2013 issue of the journal "Trials."

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics